Background Bryan Johnson, born in 1977, is a tech entrepreneur and founder of Blueprint, spending approximately $2 million annually on an extensive anti-aging regimen. His program includes over 100 daily supplements, strict diet control, constant health monitoring, and experimental treatments like plasma exchanges. Johnson claims his biological markers show significant age reversal, though these claims are debated by medical professionals.
Resolution Criteria This market will resolve YES if Bryan Johnson outlives 99% of americans born in 1977 (his birth year). It will resolve NO if he dies before reaching this threshold. Resolution will be determined using:
Official death records or widely reported news of Johnson's death
CDC or equivalent demographic data showing the percentage of 1977-born individuals still living at the time of Johnson's death
If Johnson dies before 99% of his birth cohort, the market resolves NO immediately
If Johnson is still alive when 99% of his birth cohort has died, the market resolves YES
Considerations
This is a long-term market that could take decades to resolve
Current life expectancy data and mortality tables may not accurately predict future trends due to potential medical advances
Johnson's experimental anti-aging protocols lack scientific validation and could have unknown long-term effects
The accuracy of tracking the survival rate of the 1977 birth cohort may become challenging over time
Global catastrophic events could significantly impact mortality rates for this generation